News Snapshot:
NEW DELHI – Early this month, Nepal’s minister of state for health Umesh Shrestha announced that half of the country’s population had received Sinopharm, the Chinese Covid-19 vaccine, or 149 million doses in total. Sri Lanka and Bangladesh have both agreed to manufacture Sinopharm, with the latter getting more than 26 million doses of the vaccine separately. The pandemic has given China another opportunity to make inroads by offering vaccines and developmental funds for health infrastructure; at times aid from Beijing has outstripped that provided by India, the predominant power in the region, as well as the US. China has...
